Please login to the form below

Taflinar

This page shows the latest Taflinar news and features for those working in and with pharma, biotech and healthcare.

BMS gets two new cancer approvals in Europe

all patents regardless of their BRAF status, potentially making it more useful than BRAF inhibitors such as Roche's Zelboraf (vemurafenib) and Novartis' Taflinar (dabrafenib).

Latest news

BMS bags US approval for Opdivo and Yervoy combo

inhibitors such as Roche's Zelboraf (vemurafenib) and GSK's Taflinar (dabrafenib).
NICE backs GSK’s Tafinlar for skin cancer

NICE said the information provided by GSK suggested that Taflinar works as well as Zelboraf, which also targets the BRAF V600 mutations.
NICE fast-tracks GSK's skin cancer drug Tafinlar

However, just as Roche was forced to discount Zelboraf's price before NICE recommended it, the new Taflinar guidance was only issued on the basis GSK discount its drug's list ... Taflinar was approved in Europe in August 2013, based on phase III results
GSK's personalised cancer drug Tafinlar set for European approval

Regulatory advisors recommend the melanoma drug be licensed

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Editorial Director – Medical Education – Oxford: Negotiable

Senior Medical Writer: Great salary and benefits

Medical Writer, e-learning/ training, London: Excellent Salary

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Senior Account Manager or AD - Medical Communications: Salary TBC

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Scientific Director: Great salary and bebefits

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Project Manager, Medical Communications, London: Excellent Salary

Medical Writer - (London, Brighton or Copenhagen): Competitive

Account Manager – Med Comms – London: Salary TBC

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Senior Account Manager – Med Comms – Kent: Salary TBC

Senior Account Director, Healthcare Brand Communications, London: Excellent Package

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Group Account Director, Healthcare Brand Communications, London: Excellent Package

Editor – Medical Education Agency – Bucks: Salary TBC

Project Manager, Medical Communications, Oxford: Excellent Salary

Senior Account Manager / Account Director: Great salary and bebefits

Subscribe to our email news alerts

No results were found

PMHub

Add my company

Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation: HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...